Dr Rachel Orme

Specialises in chest pain, acute coronary syndromes, coronary intervention and lipid lowering therapy. 

About Dr Rachel Orme 

Dr Rachel Orme is an interventional and general cardiologist who completed her training and worked as a consultant cardiologist at a large tertiary teaching hospital in Sheffield (UK) before relocating to Perth. 

Rachel has a comprehensive background including experience and training in the diagnosis, treatment and management of Ischaemic Heart Disease, Heart failure, Cardiac Rhythm Management, Pregnancy and Heart Disease, Inherited Cardiac Conditions and Adult Congenital Heart Disease. 

Rachel has broad experience in the management of primary, acute and elective percutaneous coronary intervention. Her research interests are in the medications used in the management of coronary artery disease treated by angioplasty and management of the risk factors associated with the development of cardiovascular heart disease.

Rachel is also particularly interested the management heart failure.

Rachel is very settled in WA and when she is not at work you can find Rachel at the beach with her dogs and two daughters.

Publications

• Monitoring Antiplatelet Therapy. Orme R, Judge HM, Storey RF, Seminars in Thrombosis and Haemostasis 2016.
• An unusual cause of breathlessness. Orme R, Hill C, Allahabadia A, Harrison B, Grech E. BMJ. 2013 Sep 19;347:f5318. doi: 10.1136/bmj.f5318.
• Role of frailty assessment in patients undergoing cardiac interventions. Rowe R, Iqbal J, Murali-Krishnan R, Sultan A, Orme R, Briffa N, Denvir M, Gunn J. Open Heart. 2014 Feb 1;1(1):e000033. doi: 10.1136/openhrt-2013-0000333. eCollection 2014.
• Coronary artery spasm: mimicry, misdiagnosis and misfortune. Kamaruddin H, Orme R, Hall IR, Gunn J. BMJ Case Rep. 2015 Mar 26;2015:bcr2014204519. doi: 10.1136/bcr-2014-204519.
• Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Parker WAE, Orme RX, Hanson J, Stokes HM, Bridge CM, Shaw PA, Sumaya W, Thorneycroft K, Petrucci G, Porro B, Judge HM, Ajjan RA, Rocca B, Storey RF. Platelets. 2019;30(2):148-157. doi: 10.1080/09537104.2019.1572880. Epub 2019 Feb 13.
• https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.034790
• Type F Congenital Quadricuspid Aortic Valve: A Very Rare Case Diagnosed by 3-dimenional Transoesophageal Echocardiography. Garg P, Kamaruddin H, Orme R, Watt V. Open Cardiovasc Med J. 2014 Mar 7;8:23-5. doi: 10.2174/1874192401408010023. eCollection 2014.
• Study of medications used in the management of patients with coronary artery disease undergoing percutaneous coronary intervention. Sumaya W, Parker WAE, Judge HM, Hall IR, Orme RC, Adam Z, Richardson JD, Rothman AMK, Morgan KP, Gunn JP, Storey RF. Platelets. 2020 Jun 16:1-5. doi: 10.1080/09537104.2020.1779925.

Professional Memberships

• Fellowship of the Royal Australasian College of Physicians